Ashish Manne/X
May 28, 2025, 10:09
Ashish Manne: The Potential of Cell-Free DNA Methylation Sequencing in Pancreatic Ductal Adenocarcinoma
Ashish Manne, GI Medical Oncologist and Associate Professor at Ohio State University Comprehensive Cancer Center, shared a post on LinkedIn:
“Excited to share that we’ll be presenting our latest work at ASCO25!
Our poster highlights the potential of cell-free DNA methylation sequencing to better understand and predict treatment response in pancreatic ductal adenocarcinoma (PDA).
This work reflects our continued focus on decoding the biology of PDA — because in this disease, Biology Is King.
Looking forward to connecting with colleagues and collaborators in Chicago!”
Ashish Manne announced his team’s upcoming presentation at ASCO 2025, focusing on the use of cfDNA methylation sequencing to improve treatment response prediction in pancreatic ductal adenocarcinoma.
More posts on Adenocarcinoma on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 7, 2025, 17:41
Jun 7, 2025, 16:47
Jun 7, 2025, 16:40
Jun 7, 2025, 16:30
Jun 7, 2025, 16:07
Jun 7, 2025, 15:49